Detection of microchimerism by minor histocompatibility antigen HA-1 allele-specific nested polymerase chain reaction

被引:4
作者
Wieles, B
Pool, J
Derks, R
Burlingham, WJ
Goulmy, E
机构
[1] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands
[2] Univ Wisconsin, Dept Surg, Madison, WI USA
关键词
minor histocompatibility antigen; microchimerism; nested PCR;
D O I
10.1016/j.bbmt.2005.01.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A minor histocompatibility antigens (mHags) can induce T-cell reactivities with important consequences for the graft-versus-leukemia effect and the development of graft-versus-host disease in IIIA-matched stem cell transplantation settings. Recently, m-Hag-specific T cells were also demonstrated in multiparous woman and in solid organ transplant recipients. Microchimeric cells have been detected in the latter settings. To study whether microchimerism is instrumental in the induction and/or maintenance of mHag T cells, we developed an HA-1 allele-specific nested polymerase chain reaction. To optimize and validate the reliability of this method at different levels of microchimerism, serial dilutions of HA-1(H) cells titrated into HA-1(R) cells were tested. We demonstrated that tire HA-1(H) allele can be reliably and consistently detected at concentrations as low as 1:10(5) without losing specificity.. The developed HA-1-specific nested polymerase chain reaction is an important tool that facilitates the detection of HA-1 microchimerism in various clinical specimens and that promotes investigation of the effects of microchimerism on induction of mHag-specific T cells in the various settings of immunization. (C) 2005 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:345 / 348
页数:4
相关论文
共 12 条
[1]   Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance [J].
Cai, JC ;
Lee, J ;
Jankowska-Gan, E ;
Derks, R ;
Pool, J ;
Mutis, T ;
Goulmy, E ;
Burlingham, WJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (07) :1017-1023
[2]   The minor histocompatibility antigen HA-1: A diallelic gene with a single amino acid polymorphism [J].
den Haan, JMM ;
Meadows, LM ;
Wang, W ;
Pool, J ;
Blokland, E ;
Bishop, TL ;
Reinhardus, C ;
Shabanowitz, J ;
Offringa, R ;
Hunt, DF ;
Engelhard, VH ;
Goulmy, E .
SCIENCE, 1998, 279 (5353) :1054-1057
[3]   Real-time quantitative y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation [J].
Fehse, B ;
Chukhlovin, A ;
Kühlcke, K ;
Marinetz, O ;
Vorwig, O ;
Renges, H ;
Krüger, W ;
Zabelina, T ;
Dudina, O ;
Finckenstein, FG ;
Kröger, N ;
Kabisch, H ;
Hochhaus, A ;
Zander, AR .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2001, 10 (03) :419-425
[4]   How should chimerism be decoded? [J].
Ferrand, C ;
Perruche, S ;
Robinet, E ;
Martens, A ;
Tiberghien, P ;
Saas, P .
TRANSPLANTATION, 2003, 75 (09) :50S-54S
[5]   A MINOR TRANSPLANTATION ANTIGEN DETECTED BY MHC-RESTRICTED CYTO-TOXIC LYMPHOCYTES-T DURING GRAFT-VERSUS-HOST DISEASE [J].
GOULMY, E ;
GRATAMA, JW ;
BLOKLAND, E ;
ZWAAN, FE ;
VANROOD, JJ .
NATURE, 1983, 302 (5904) :159-161
[6]   Minor histocompatibility antigens: Allo target molecules for tumor-specific immunotherapy [J].
Goulmy, E .
CANCER JOURNAL, 2004, 10 (01) :1-7
[7]   Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans [J].
James, E ;
Chai, JG ;
Dewchand, H ;
Macchiarulo, E ;
Dazzi, F ;
Simpson, E .
BLOOD, 2003, 102 (01) :388-393
[8]   Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: Extinction of graft-versus-leukemia effects after conversion to full donor chimerism [J].
Mapara, MY ;
Kim, YM ;
Marx, J ;
Sykes, M .
TRANSPLANTATION, 2003, 76 (02) :297-305
[9]   Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1 [J].
Mommaas, B ;
Stegehuis-Kamp, JA ;
van Halteren, AG ;
Kester, M ;
Enczmann, J ;
Wernet, P ;
Kögler, G ;
Mutis, T ;
Brand, A ;
Goulmy, E .
BLOOD, 2005, 105 (04) :1823-1827
[10]   Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens [J].
Mutis, T ;
Verdijk, R ;
Schrama, E ;
Esendam, B ;
Brand, A ;
Goulmy, E .
BLOOD, 1999, 93 (07) :2336-2341